AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Feb 28, 2011
30016_dirs_2011-02-28_13990810-a4df-4652-999f-bbc228e4cb58.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-02-25
Reporting Person: DEADY CONAN R (Corp VP, General Counsel & Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-25 | Common Stock | M | 23054 | $17.1350 | Acquired | 42401 | Direct |
| 2011-02-25 | Common Stock | M | 18072 | $25.45 | Acquired | 60473 | Direct |
| 2011-02-25 | Common Stock | M | 9472 | $38.3350 | Acquired | 69945 | Direct |
| 2011-02-25 | Common Stock | S | 43484 | $77.048 | Disposed | 26461 | Direct |
| 2011-02-25 | Common Stock | S | 7114 | $75.8462 | Disposed | 19347 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-25 | Non-Qualified Stock Option (right to buy) | $17.1350 | M | 23054 | Disposed | 2013-02-06 | Common Stock (23054) | Direct |
| 2011-02-25 | Non-Qualified Stock Option (right to buy) | $25.45 | M | 18072 | Disposed | 2014-02-04 | Common Stock (18072) | Direct |
| 2011-02-25 | Non-Qualified Stock Option (right to buy) | $38.3350 | M | 9472 | Disposed | 2013-02-13 | Common Stock (9472) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.33 to $76.57, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $76.31 to $75.80, inclusive.
F3: Grant of options to buy shares of common stock becomes exercisable as to 6,400 shares on 02/06/2004, 02/06/2005, 02/06/2006, 02/06/2007, and the remaining 564 shares on 02/06/2008.
F4: Grant of options to buy shares of common stock becomes exercisable as to 4,400 shares on 02/05/2005, 02/05/2006, 02/05/2007, 02/05/2008, and the remaining 472 shares on 02/05/2009.
F5: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2007) of the date of grant.